FineMark National Bank & Trust Lowers Stock Position in Procter & Gamble Company (The) $PG

FineMark National Bank & Trust cut its holdings in shares of Procter & Gamble Company (The) (NYSE:PGFree Report) by 6.0% during the second quarter, Holdings Channel.com reports. The firm owned 150,134 shares of the company’s stock after selling 9,567 shares during the period. Procter & Gamble makes up 0.8% of FineMark National Bank & Trust’s holdings, making the stock its 26th biggest holding. FineMark National Bank & Trust’s holdings in Procter & Gamble were worth $23,919,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the stock. Vanguard Group Inc. increased its holdings in shares of Procter & Gamble by 1.4% in the 2nd quarter. Vanguard Group Inc. now owns 233,211,283 shares of the company’s stock valued at $37,155,222,000 after acquiring an additional 3,189,111 shares during the period. Kingstone Capital Partners Texas LLC boosted its position in Procter & Gamble by 655,209.0% during the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after purchasing an additional 76,017,350 shares in the last quarter. Geode Capital Management LLC grew its stake in Procter & Gamble by 1.8% in the second quarter. Geode Capital Management LLC now owns 59,415,933 shares of the company’s stock valued at $9,439,341,000 after purchasing an additional 1,060,713 shares during the last quarter. Northern Trust Corp raised its holdings in Procter & Gamble by 0.8% in the first quarter. Northern Trust Corp now owns 29,644,000 shares of the company’s stock worth $5,051,930,000 after purchasing an additional 248,792 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD lifted its position in shares of Procter & Gamble by 13.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after buying an additional 2,466,308 shares during the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

Shares of PG opened at $146.99 on Wednesday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.51 and a current ratio of 0.71. The stock has a 50-day moving average of $151.31 and a two-hundred day moving average of $156.33. The stock has a market cap of $343.47 billion, a P/E ratio of 21.46, a P/E/G ratio of 3.87 and a beta of 0.36. Procter & Gamble Company has a one year low of $144.09 and a one year high of $180.43.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings data on Friday, October 24th. The company reported $1.99 earnings per share for the quarter, beating analysts’ consensus estimates of $1.90 by $0.09. Procter & Gamble had a return on equity of 32.63% and a net margin of 19.74%.The business had revenue of $22.39 billion for the quarter, compared to analyst estimates of $22.23 billion. During the same period in the prior year, the company earned $1.93 earnings per share. The company’s revenue was up 3.0% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. As a group, research analysts predict that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, November 17th. Shareholders of record on Friday, October 24th were paid a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a yield of 2.9%. The ex-dividend date was Friday, October 24th. Procter & Gamble’s payout ratio is presently 61.61%.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on PG. BNP Paribas reaffirmed an “outperform” rating and issued a $177.00 price objective on shares of Procter & Gamble in a research report on Friday, August 15th. Dbs Bank raised shares of Procter & Gamble to a “moderate buy” rating in a report on Tuesday, October 28th. UBS Group decreased their price objective on Procter & Gamble from $180.00 to $176.00 and set a “buy” rating for the company in a report on Wednesday, October 8th. BNP Paribas Exane lowered their price objective on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a research report on Tuesday, September 23rd. Finally, Barclays reduced their target price on Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 1st. Twelve investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat.com, Procter & Gamble presently has an average rating of “Moderate Buy” and an average price target of $171.53.

Check Out Our Latest Research Report on Procter & Gamble

Insiders Place Their Bets

In other news, CEO Gary A. Coombe sold 3,535 shares of the stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $538,133.05. Following the sale, the chief executive officer owned 34,816 shares in the company, valued at $5,300,039.68. This represents a 9.22% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Jennifer L. Davis sold 3,227 shares of the business’s stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $491,246.21. Following the transaction, the chief executive officer owned 61,764 shares of the company’s stock, valued at $9,402,333.72. This represents a 4.97% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 51,056 shares of company stock worth $7,892,036. Company insiders own 0.20% of the company’s stock.

About Procter & Gamble

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Read More

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.